￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
028-123456789
Menu

Medical News

U.S. FDA grants Xalkori (crizotinib) breakthrough drug status

2025-10-19 11:44:20

Check Details
The effectiveness of Xalkori in the first-line treatment of advanced non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Precautions for patients with lung cancer using Xacori (crizotinib)

2025-10-19 11:44:20

Check Details
Efficacy and safety of crizotinib

2025-10-19 11:44:20

Check Details
Medical insurance reimbursement conditions for Xalkori (crizotinib) in 2021

2025-10-19 11:44:20

Check Details
Xalkori has very good results in the treatment of ALK-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Application of Xalkori (crizotinib) in ROS1-rearranged non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Can all cancers with NTRK gene fusions be treated with larotrectinib?

2025-10-19 11:44:20

Check Details
How much does a box of larotrectinib cost? Do you have medical insurance?

2025-10-19 11:44:20

Check Details
Efficacy and Safety of Crizotinib (Xalkori) in Patients with Lung Cancer

2025-10-19 11:44:20

Check Details
Will larotrectinib be included in the national medical insurance in China in 2021?

2025-10-19 11:44:20

Check Details
Where can I buy larotrectinib in China? How much does a box cost?

2025-10-19 11:44:20

Check Details
Category
相关知识